Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
Revolution Medicines’ Acquisition of EQRx
Silver Lake and CPP Investments’ $12.5 Billion Acquisition of Qualtrics International
Goodwin Procter advised Qualtrics International Inc. on the deal. Qualtrics International Inc. (NASDAQ: XM) announced its definitive agreement to be acquired by Silver Lake, in partnership...
Citrix Systems’ $16.5 Billion Acquisition of Vista Equity Partners and Evergreen Coast Capital’s Affiliates
Goodwin Procter advised Citrix Systems on the deal. Citrix Systems announced its acquisition by affiliates of Vista Equity Partners and Evergreen Coast Capital Corporation, an affiliate of...
Synaptics Incorporated’s Acquisition of DSP Group
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...